“…It has been reported that overexpression of some AQPs in cancer cells, especially AQP5, aggravated epithelial-mesenchymal transition (EMT) and increased cancer cell migration (7)(8)(9). However, we recently showed that overexpression of AQP5 in Madin-Darby canine kidney (MDCK) cells, a noncancerous epithelial cell line, did not increase levels of the mesenchymal marker vimentin, even though it facilitated a decrease of the epithelial marker E-cadherin (10). Thus, the AQP5-mediated decrease in E-cadherin levels in MDCK cells was not associated with EMT, highlighting discrepancies in AQP5associated phenotypes between normal epithelial cells and ABBREVIATIONS: 3T3, 3-d transfer, inoculum 3 3 10 5 ; AQP, aquaporin; AQP3 LD5 , AQP3 with an AQP5 loop D substitution; AQP3 Tail5 , AQP3 with an AQP5 tail substitution; BSA, bovine serum albumin; EGF, epidermal growth factor; EGFP, enhanced green fluorescent protein; EMT, epithelial-mesenchymal transition; FBS, fetal bovine serum; FISH, fluorescence in situ hybridization; GFP, green fluorescent protein; HEK, human embryonic kidney; IRES, internal ribosome entry site; MDCK, Madin-Darby canine kidney; PFA, paraformaldehyde; PIV, particle image velocimetry; SSC, saline sodium citrate; ZO1, zonula occludens-1 different cancer cells.…”